Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC.
about
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaTransarterial radioembolization for hepatocellular carcinoma: a reviewTherapeutic Strategies in HCC: Radiation ModalitiesDiagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and DevelopmentsCurrent status of transarterial radioembolizationTransarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular CarcinomaTreatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive reviewExtending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization)Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upSystematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsChallenges of advanced hepatocellular carcinomaTransarterial radioembolization for hepatocellular carcinoma: An update and perspectivesSelective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma.Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells.Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor modelCurrent management of hepatocellular carcinoma: an Eastern perspective.Sorafenib: 10 years after the first pivotal trial.Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017.Current role of selective internal radiation with yttrium-90 in liver tumors.Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.New concepts in embolotherapy of HCC.Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.Cost-effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma.Das hepatozelluläre KarzinomIntra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial
P2860
Q24186130-EAEE5356-6BB0-4BA8-84B0-7F0231F5286AQ26738273-A035943A-59B0-46E1-9621-BCF8FBEA0C24Q26738658-8B35F68F-F843-484A-8234-CF49518FCC97Q26740315-C673A518-E62C-4353-928B-233971C9FCB2Q26744307-798B3F13-4694-457B-9F89-8ADF53DEC28FQ26753089-BFAA51A1-9F43-45E9-AA19-CEA3253E711EQ26772299-8F78CD11-18D2-4EAC-B831-E7B7C03B7914Q26796524-700AA641-3AD7-4849-8F82-DD7FE031BA22Q26851033-09D4D5E9-9C52-45AC-9A4A-C4C6E2F9668BQ27007847-FC9F9D22-E1C0-43F1-B976-C71843E29BFFQ28076867-A5113F25-271B-4EED-86B9-ECAEB8EEB02FQ28081783-B45069B9-F587-4C35-B4C7-8491D0BE5F86Q33593257-D73540A8-FB1F-4F19-A029-8698E06FE285Q36425785-677BA48F-5F7E-4F55-A087-32FA540E3AD5Q37114870-264B4D01-7CFC-455E-B560-BB9017D3247DQ38410816-2519B790-B3F3-4805-9422-75D4D47EE284Q38544841-8743C7BE-8DA5-4588-A316-5C7DFFF8E9F7Q38673823-A0CEEB4C-FF32-4EA2-82D0-E4DD53B4C8B2Q38786064-F6C716A2-787F-41A3-86F0-EFF18EC3F9C8Q38792625-32FB30CE-03A1-4226-89D6-0D55EE3A2183Q38904263-15B2C646-2A03-4A5C-83E2-92C3FCA8BE38Q47134709-8E282C69-56FE-4E5C-A5EC-36289CF3CA7BQ47325384-1927009A-E745-4383-A872-C871B6B93B6AQ58011404-00936C9C-3F65-4633-A68E-741E5B4AEA34Q58776805-551140D0-348D-438A-A443-983AA0146382
P2860
Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Safety and toxicity of radioem ...... ean multicentre trial SORAMIC.
@en
Safety and toxicity of radioem ...... ean multicentre trial SORAMIC.
@nl
type
label
Safety and toxicity of radioem ...... ean multicentre trial SORAMIC.
@en
Safety and toxicity of radioem ...... ean multicentre trial SORAMIC.
@nl
prefLabel
Safety and toxicity of radioem ...... ean multicentre trial SORAMIC.
@en
Safety and toxicity of radioem ...... ean multicentre trial SORAMIC.
@nl
P2093
P2860
P356
P1433
P1476
Safety and toxicity of radioem ...... ean multicentre trial SORAMIC.
@en
P2093
Chris Verslype
Eckart Schott
Frank Kolligs
Jens Ricke
Jerzy Walecki
Karsten Bulla
Kerstin Schütte
Markus Peck-Radosavljevic
Peter Reimer
SORAMIC study group
P2860
P304
P356
10.1111/LIV.12622
P577
2014-07-08T00:00:00Z